Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,078 | 135,586 | 106,095 | 89,137 | 47,521 |
| Marketable Securities | 363,974 | 155,444 | 208,393 | 231,428 | 250,869 |
| Receivables | 33,034 | 26,122 | 17,825 | 18,512 | 19,306 |
| Inventories | 22,107 | 18,872 | 19,316 | 18,741 | 13,895 |
| TOTAL | $494,802 | $360,680 | $369,288 | $374,200 | $340,341 |
| Non-Current Assets | |||||
| PPE Net | 237 | 297 | 462 | 632 | 801 |
| Intangibles | 5,533 | 5,747 | 5,960 | 6,174 | 6,388 |
| Other Non-Current Assets | 6,302 | 6,009 | 10,975 | 11,267 | 16,042 |
| TOTAL | $12,072 | $12,053 | $17,397 | $18,073 | $23,231 |
| Total Assets | $506,874 | $372,733 | $386,685 | $392,273 | $363,572 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,631 | 15,982 | 11,912 | 12,328 | 4,887 |
| Accrued Expenses | 84,456 | 69,185 | 59,314 | 62,658 | 54,797 |
| Other current liabilities | 0 | 40,000 | 38,783 | 37,704 | 36,635 |
| TOTAL | $104,267 | $129,455 | $111,823 | $115,517 | $97,605 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,556 | 3,778 | 1,590 | 2,827 | 1,286 |
| Other Non-Current Liabilities | 3,515 | 3,681 | 3,839 | 3,938 | 4,030 |
| TOTAL | $106,924 | $109,695 | $111,773 | $112,207 | $113,271 |
| Total Liabilities | $211,191 | $239,150 | $223,596 | $227,724 | $210,876 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,736 | 66,420 | 63,621 | 63,224 | 61,457 |
| Common Shares | 67 | 64 | 62 | 61 | 61 |
| Retained earnings | -1,304,372 | -1,251,468 | -1,204,836 | -1,155,338 | -1,112,010 |
| Other shareholders' equity | 145,940 | 143,243 | 144,091 | 142,781 | 140,877 |
| TOTAL | $295,683 | $133,583 | $163,089 | $164,549 | $152,696 |
| Total Liabilities And Equity | $506,874 | $372,733 | $386,685 | $392,273 | $363,572 |